Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Weaver

Showing results (201-210 of 203) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 203 results.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 6, 2014
PRONOUNCE: randomized, open-label, phase III study of first-line pemetrexed + carboplatin followed by maintenance pemetrexed versus paclitaxel + carboplatin + bevacizumab followed by maintenance bevacizumab in patients ith advanced nonsquamous non-small-cell lung cancerRalph G Zinner, Coleman K Obasaju, David R Spigel, et al.
Science Translational Medicine|July 9, 2025
Antitrypanosomal quinazolines targeting lysyl-tRNA synthetase show partial efficacy in a mouse model of acute Chagas diseaseLindsay B Tulloch, Hugh Tawell, Annie E Taylor, et al.
Science (New York, N.Y.)|September 10, 2005
Deep Impact: observations from a worldwide Earth-based campaignK J Meech, N Ageorges, M F A'Hearn, et al.
Pageof 21

Showing results (201-210 of 203) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 203 results.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 6, 2014
PRONOUNCE: randomized, open-label, phase III study of first-line pemetrexed + carboplatin followed by maintenance pemetrexed versus paclitaxel + carboplatin + bevacizumab followed by maintenance bevacizumab in patients ith advanced nonsquamous non-small-cell lung cancerRalph G Zinner, Coleman K Obasaju, David R Spigel, et al.
Science Translational Medicine|July 9, 2025
Antitrypanosomal quinazolines targeting lysyl-tRNA synthetase show partial efficacy in a mouse model of acute Chagas diseaseLindsay B Tulloch, Hugh Tawell, Annie E Taylor, et al.
Science (New York, N.Y.)|September 10, 2005
Deep Impact: observations from a worldwide Earth-based campaignK J Meech, N Ageorges, M F A'Hearn, et al.
Pageof 21